Description

LENVATINIB is an anti-cancer medicine used in the treatment of various types of cancers. Cancer is a disease caused by the abnormal growth of cells that divide uncontrollably. This medicine is used in treating hepatocellular carcinoma as a first-line therapy, differentiated thyroid cancer in patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory, advanced renal cell carcinoma in combination with pembrolizumab, and advanced endometrial cancer in combination with pembrolizumab.

LENVATINIB contains Lenvatinib, which belongs to the class of medicines known as kinase inhibitors. It works by inhibiting the action of an enzyme (tyrosine kinase) and thus stops the abnormal growth of cancer cells.

LENVATINIB may cause certain side effects such as diarrhoea, decreased appetite, nausea, vomiting, tiredness, itching, rash, headache, cough, abdominal pain, hoarseness, and dizziness. Inform your doctor if any of these side effects bother you. LENVATINIB should be taken as prescribed by your doctor. Do not take more than the recommended dose of medicine.

If you are allergic to LENVATINIB or its components, inform your doctor. Before taking LENVATINIB, inform your doctor if you have/had liver or kidney disease, calcium deficiency, heart problems, increased blood pressure, seizures, bleeding disorders, vision problems, and a history of blood clots. This medicine is known to cause embryo-fetal toxicity. It is not recommended for use in pregnancy and breastfeeding. 

Uses of LENVATINIB

Renal Cell Carcinoma, Hepatocellular carcinoma, Differentiated thyroid cancer, Endometrial cancer.

Medicinal Benefits

LENVATINIB contains Lenvatinib, which is used in treating different types of cancer. It works by stopping the action of a tyrosine kinase enzyme that causes the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body. It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, LENVATINIB stops the body’s production, spread and growth of cancerous cells.

Directions for Use

Take LENVATINIB as prescribed by the doctor. It can be taken with or without food. Swallow it as a whole with a glass of water. Do not crush, break, or chew it. It is advised not to take more than the recommended dose of medicine.

Storage

Store in a cool and dry place away from sunlight

Side Effects of LENVATINIB

• Nausea
• Vomiting
• Diarrhoea
• Loss of appetite
• Tiredness
• Muscle/joint pain
• Dizziness
• Weakness
• Cough
• Headache
• Itching
• Rash
• Decreased weight
• Abdominal pain
• Vision problem